All In MedTech

Device Trial Radar · NCT07949747

Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

A Prospective Clinical Study Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular Indications

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

25

Planned (sponsor's estimate)

Start

Jul 6, 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
University of California, IrvineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Candela Corporation
First posted
Nov 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this prospective clinical study is to evaluate pulsed dye laser treatment parameters on the clearance of vascular indications, including rosacea and port wine capillary malformations. The main question it aims to answer is: \- Does the use of post-cooling, compared with no post-cooling, affect patient-reported pain scores and treatment outcomes after one treatment session? Participants will: * Receive PDL treatment according to the study protocol. * Complete all required follow-up visits and questionnaires. * Undergo OCT imaging assessments, as applicable to the study protocol.

Conditions

  • Rosacea
  • Scars
  • Port Wine Capillary Malformations

Interventions

  • Laser with DCD Pre- and Post-CoolingDevice

    Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 1: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/10-20 ms

  • Laser with Standard DCD Pre-Cooling OnlyDevice

    Study subject will undergo informed consent procedure, eligibility screening, and enrollment to receive treatment to one or more treatment areas depending on the presenting condition and principal investigator assessment. Study subject may receive 1-3 treatments within the study with 4-12 weeks between each treatment visit. Two test areas will be determined in the area(s) of the vascular condition. Each lesion will serve as its own control, since it is divided in half and each side receives a different set of laser settings. The following laser settings will be applied: Area 2: Spot size 7-15mm; pulse duration 1.5-10 ms; fluence 5-8 j/cm2; cooling settings 10-30/20-30/0 ms

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Effect of Pre- and Post-Cooling on Patient Reported Discomfort as Evaluated by Responses to Two-Part Post-Treatment QuestionnaireTime frame: From date of first treatment until study completion, assessed up to 52 weeks.
  2. Patient-Reported Evaluation of Improvement as Assessed by Participant QuestionnaireTime frame: From date of first treatment until study completion, assessed up to 52 weeks.
  3. Blinded Physician EvaluationTime frame: Up to 52 weeks.

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California, Irvine

    Irvine, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.